Our Advocacy

Aotearoa New Zealand Digital Mental Health Roadmap

DHA Letter to the Incoming Minister of Health – Hon Simeon Brown

This letter from the DHA’s CEO to New Zealand’s Health Minister introduces their briefing document with five key recommendations: increasing digital health funding to 5% of Vote Health, creating a Health Infrastructure Entity, modernizing procurement, developing public-private partnerships, and restoring critical digital programs. It emphasizes collaborative partnership between government and industry to advance digital health solutions.

DHA Briefing to the Incoming Minister

The Digital Health Association’s briefing urges New Zealand’s incoming Health Minister to increase investment in digital health infrastructure to enable better healthcare outcomes. It recommends establishing a Health Infrastructure Entity, enhancing procurement practices, leveraging public-private partnerships, and restoring critical digital programs paused by budget cuts.

DHA Letter to the Incoming Minister of Health, Hon Simeon Brown

This submission from Ryl Jensen, CEO of the Digital Health Association, urges Hon Simeon Brown to prioritise digital health amid $500 million in funding cuts. It advocates for investment in digital infrastructure, interoperable data systems, and public-private partnerships to drive efficiency and equity.

Digital Mental Health Summit Report

The Digital Mental Health Summit Report (December 2024) outlines key discussions, challenges, and solutions from a national summit focused on enhancing digital mental health and addiction services in New Zealand. It explores the vision for a Digital Mental Health Hub, identifies gaps in the sector, and presents actionable strategies for improving digital integration, accessibility, and service delivery.

Live Stream: DHA submission to the Foreign Affairs, Defence and Trade Committee

The DHA’s submission highlights non-tariff barriers restricting digital health exports, urging government action on regulation, trade, infrastructure, and procurement. CEO Ryl Jensen shares industry examples, calling for policy changes to support growth and global competitiveness.

DHA Submission to the Foreign Affairs, Defence and Trade Committee

The Digital Health Association highlights non-tariff barriers limiting New Zealand’s digital health exports and sector growth.

Submission on the Repeal of the Therapeutic Products Act

The DHA’s submission supports repealing the Therapeutic Products Act, arguing its broad SaMD regulation stifles innovation, increases costs, and limits digital health progress. CEO Ryl Jensen urges agile, risk-proportionate legislation that ensures safety while supporting industry growth and efficiency.

DHA Briefing to the Incoming Minister

The DHA’s Briefing urges government action on digital health governance, funding, interoperability, and workforce training. CEO Ryl Jensen calls for a Digital Health Agency and investment to boost healthcare efficiency, innovation, and resilience.

DHA Supplementary Order Paper for SaMD

The following document is a Supplementary Order Paper the DHA had constructed as part of our submission for SaMD.

Further evidence on SaMD to the Health Select Committee

The following document is further evidence presented to the Health Select Committee by the DHA on the regulation of Software as a Medical Device and the problems associated with poor regulation.

DHA Submission on the Therapeutic Products Bill 2022

The DHA’s final submission warns that broad SaMD regulations could stifle innovation and growth. CEO Ryl Jensen urges risk-based, proportionate legislation to support digital health progress while ensuring patient safety.

HGM Memorandum Therapeutic Products Bill

The DHA’s memorandum outlines compliance risks in the Therapeutic Products Bill 2022, urging member feedback to ensure balanced SaMD regulation that supports innovation and growth.